Comparing filtering methods for pediatric heart surgery
Part of Immune system & allergy clinical trials.
This trial compares two ways to filter blood during heart surgery in young children to see which method works better. It may help kids under 5 who need heart surgery with a heart-lung machine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is under 5 years old
- Your child needs heart surgery with a heart-lung machine
- Your child does not have other serious illnesses like autoimmune disease or active infections
- Your child has not had a recent viral illness such as COVID or flu within 30 days
- Your child is not currently taking steroid medications
- Your child is not on ECMO or having emergency surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of using the heart-lung machine during bypass surgery to see which causes less inflammation and stress on the body. It may help doctors choose the best approach for future patients.
This trial tests if dexmedetomidine or methylprednisolone is better at reducing inflammation during coronary artery bypass grafting (CABG) with a heart-lung machine. The goal is to find a treatment that helps patients recover better.
This trial tests a new device that measures heart function closely after heart surgery. It may help doctors give better care if you are in the heart intensive care unit after your operation.
This study tests whether using a special blood filter during heart surgery can reduce harmful inflammation. It may help children recover better after long surgeries.
This trial studies patterns in immune cells (neutrophils) in very young children who undergo heart surgery using a heart-lung machine. The goal is to better understand and potentially reduce lung injury after surgery.
This trial tests whether giving methylprednisolone (a steroid medicine) can lower the body’s inflammatory response in children during the first day after congenital open-heart surgery. It may help reduce harmful inflammation and improve recovery for some children undergoing their first surgery.
Hear when a new Systemic Inflammatory Response Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.